Proton MR Spectroscopy and 18F-Fluorocholine PET for Breast Cancer Diagnosis

NCT01956409 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer Diagnosis
Positron Emission Tomography
Magnetic Resonance Imaging

Interventions

DRUG: 18F-FCH
DRUG: Magnevist

Sponsor

National Taiwan University Hospital